Wound Healing Industry Articles & Analysis
15 news found
Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of two innovative cell therapy assets from Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business. The acquisition enables Healiva® to establish one of the world’s broadest portfolios of affordable, ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
Tyler built a successful track record for operation excellence specifically in the wound care industry as COO with National Healing which later became Healogics. ...
The company also announces growth through a medical non-wound care vertical market expansion in Sports Medicine and Aesthetics. ...
(AOTI), the leader in noninvasive sustained wound healing solutions, announced today a number of significant additions to its Leadership Team, bringing to the company over 100 years of combined strategic experience: Chief Medical Officer – Dr. ...
SFM received its third CE mark this year! Two CE marks were cleared in March 2021 for our Silver Alginates and Reinforced Silver Alginates products. SFM now holds a 510k and CE mark for its alginates range. The latest CE mark was received end of April for SFM’s latest silver nanotechnology cellulose dressings. This bolsters SFM’s ability as a legal manufacturer to support customers ...
Axio Biosolutions, a pioneering MedTech company, today announced a $6 million Series B2 equity raise led by TrueScale Capital, with participation from existing investors Omidyar Network India, University of California– Ratan Tata Fund, and Accel. Axio Biosolutions Private Limited, India (“Axio”), a wholly owned subsidiary of Boston-based Advamedica Inc. is a leading developer of ...
Updated May 12, 2021 to reflect 10 new additions, based on recent analyst reports. We’ve also updated the existing companies on the list to reflect recent business developments. From time to time, medtech analysts will call out companies in the private sector that they believe investors should be keeping tabs on. Here is our ultimate list, compiled from analyst reports, of private ...
SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced today that the Company has entered into a non-exclusive sales and marketing agreement with Ametus to market and sell the Company’s portfolio of wound care products in ...
Hybrisan, the South Wales based advanced antimicrobial specialists, have installed a new Elmarco electrospinning production line to increase the production of PPE equipment, while also accelerating product development to expand its business offering. The equipment is the first of its kind in the UK and forms part of a recent investment to aid the fight against COVID 19, using venture capital ...
Aurealis Therapeutics, a private clinical-stage biopharmaceutical company developing AUP-16, the four-in-one biologic drug for chronic non-healing wounds and regenerative diseases, announced today that Mr. Laurent Décory has joined the Board of Directors of the company as of June 10th, 2020. ...
Hybrisan, a Welsh antimicrobial specialist which is helping with the fight against the Covid-19 pandemic, has secured a £500,000 equity investment. The Port Talbot-based business has received the investment from the Development Bank of Wales, private investors and a Smart Cymru grant from the Welsh Government. Hybrisan manufactures liquid sanitiser and uses advanced nanotechnology to ...
(OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in equity and a forward commitment to provide a $5,000,000 operating line of credit, to support the FDA approval and commercial launch of Clyra's advanced wound care products. Clyra Medical Technologies holds the exclusive license to ...
Technical Absorbents Chinese Agent, Zacky Lam, was one of a number of selected presenters at the 2014 China International Wound Care and Products Conference in July. His presentation topic was'Super Absorbent Fibre (SAF) and its use within the advanced wound care ...
BioLargo, Inc. (OTCBB: BLGO) announced today that former Smith & Nephew Vice President of Innovation (and Vice President at Smith & Nephew Wound Management) Tanya Rhodes has joined the BioLargo management team as a senior strategy advisor. Rhodes will work closely with BioLargo and its recently formed medical subsidiary to commercialize its technology in the wound management and medical ...